Celularity Inc. Files 8-K on Material Agreement and Equity Sales
Ticker: CELUW · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1752828
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
Related Tickers: CELU
TL;DR
Celularity filed an 8-K for a material agreement and equity sales on 7/14.
AI Summary
Celularity Inc. filed an 8-K on July 30, 2025, reporting on events that occurred on July 14, 2025. The filing indicates an entry into a material definitive agreement and unregistered sales of equity securities. It also includes financial statements and exhibits.
Why It Matters
This filing signals potential new business dealings or financing activities for Celularity Inc., which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered equity sales, which can carry inherent risks and require further scrutiny.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- July 14, 2025 (date) — Date of earliest event reported
- July 30, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- GX Acquisition Corp. (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Celularity Inc. on July 14, 2025?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in the excerpt.
What type of equity securities were sold unregistered by Celularity Inc. on July 14, 2025?
The filing lists 'Unregistered Sales of Equity Securities' as an item, but the specific details of the securities and the terms of the sale are not elaborated in the provided text.
What is the significance of the former company name 'GX Acquisition Corp.'?
GX Acquisition Corp. was the former name of Celularity Inc., with a date of name change indicated as September 12, 2018.
What is Celularity Inc.'s Standard Industrial Classification (SIC) code?
Celularity Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Celularity Inc. headquartered?
Celularity Inc.'s business and mailing address is listed as 170 Park Ave, Florham Park, NJ 07932.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding Celularity Inc (CELUW).